Department of Medical Affairs & Pharmacovigilance • Clinical Formulary Monograph
D 92/6 Okhla Phase 1, New Delhi, 110020, India • Medical Helpline: +91 11-47532297 • Email: contact@vrmedhealthcare.com
Fusoceff-CV
Third-Generation Cephalosporin with Clavulanate Shield
Fusoceff-CV
Third-Generation Cephalosporin with Clavulanate Shield
Cefpodoxime Proxetil IP 200mg + Potassium Clavulanate Diluted IP equivalent to Clavulanic Acid 125mg
Product Clinical Overview
Fusoceff-CV is a fixed-dose oral antibacterial combination of Cefpodoxime Proxetil, an extended-spectrum third-generation cephalosporin, and Potassium Clavulanate, an irreversible beta-lactamase inhibitor. This formulation is indicated for the clinical treatment of confirmed or suspected susceptible bacterial infections of the respiratory, urinary, and dermatological systems.
More Images
Actual Fusoceff-CV packaging, label panels and blister strip.
Key Ingredients & Pharmacological Profiles
Active chemical constituents, standardized strengths, and physiological roles.
Third-generation cephalosporin prodrug that inhibits bacterial cell wall synthesis.
Beta-lactamase inhibitor protecting cefpodoxime from enzymatic inactivation.
Approved Clinical Indications
Clinical contexts where this formulation is prescribed under medical supervision.
Pharmacological Mechanism of Action
Cefpodoxime binds to penicillin-binding proteins (PBPs) in the bacterial cell wall, inhibiting transpeptidation and peptidoglycan synthesis. Potassium Clavulanate competitively and irreversibly inactivates beta-lactamase enzymes produced by resistant pathogens.
Formulation & Delivery Technology
- Potassium Clavulanate inhibits class A bacterial beta-lactamase degradation
- Favorable respiratory tissue and middle ear mucosal penetration
- Manufactured in dehumidified cleanrooms to preserve moisture-sensitive clavulanate
VR Med Healthcare Pvt. Ltd.
Registered Office & Facility:D 92/6 Okhla Phase 1, New Delhi, 110020, India
Quality Certifications:WHO-GMP Compliant & ISO 9001:2015 Certified
Medical Helpline:+91 11-47532297
Corporate Email:contact@vrmedhealthcare.com
Administration & Packaging Details
1 tablet every 12 hours after meals, strictly under prescription and guidance of a Registered Medical Practitioner.
10 x 1 x 10 Tablets (Alu-Alu Strip)
Store protected from moisture and heat at a temperature not exceeding 25°C. Keep Alu-Alu strips sealed until administration.
This formulation monograph is published strictly for the professional scientific reference and educational use of Registered Medical Practitioners, Hospitals, and Clinical Laboratories. The technical and pharmacological details presented herein do not constitute medical advice, diagnostic opinion, or therapeutic claims. These products must be prescribed, dispensed, and administered strictly in accordance with local drug regulations and under the supervision of a licensed physician. VR Med Healthcare Pvt. Ltd. does not promote self-medication, off-label usage, or unsolicited consumer health claims.
More in Antimicrobial
Enhancing Lives With
Quality Healthcare & Integrity.
VR Med Healthcare has been a trusted benchmark in the Indian pharmaceutical sector since 2010. Headquartered in Okhla Phase 1, New Delhi, our dedicated team of over 100 professionals collaborates with leading physicians and distributors across India to make premium medicines accessible and reliable.
“Our goal is to deliver quality of care in a courteous, respectful, and compassionate manner. We hope you will allow us to care for you and strive to be the first and best choice for healthcare professionals and families.”
Kamal Choudhary
Managing Director, VR Med Healthcare
Established
Approved Formulations
Healthcare Specialists
Manufacturing Standard